Latest News | Glenmark Launches Generic Glaucoma Treatment Ophthalmic Solution

New Delhi, Nov 27 (PTI) Glenmark Pharmaceuticals Inc, USA on Wednesday said it has launched Travoprost ophthalmic solution used in the treatment of glaucoma.

The Travoprost ophthalmic solution ( 0.004 per cent ionic buffered solution) is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z ophthalmic solution USP, 0.004 per cent of Sandoz, Inc, the company said in a statement.

Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for November 27, 2024 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game.

Glenmark Pharmaceuticals Inc Senior Vice President, Sales & Marketing Jim Brown said the launch of Travoprost ophthalmic solution USP, 0.004 per cent adds to the company's portfolio of prescription ophthalmic products.

"This addition highlights our commitment to meeting market needs and providing high-quality solutions for our customers," he added.

Also Read | Shillong Teer Results Today, November 27 2024: Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

Citing IQVIA sales data for the 12-month period ending September 2024, the company said Travatan Z ophthalmic solution 0.004 per cent had achieved annual sales of approximately USD 66.2 million.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)